In hepatocellular carcinoma (HCC), the induction of Kcr through siRNAs targeting histone deacetylases (HDACs) or HDAC inhibitors inhibits hepatoma cell motility and proliferation [14]. This evidence concerns the gene HDAC9 and hepatocellular carcinoma.